Status:
ACTIVE_NOT_RECRUITING
Mirtazapine for Acute and Chronic Post Mastectomy Pain
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer
Eligibility:
FEMALE
20-70 years
Phase:
EARLY_PHASE1
Brief Summary
Our aim in this study will be to investigate the effect of mirtazapine on acute post-mastectomy pain manifested by total morphine consumption in first 24 hours and VAS score at rest and movement (prim...
Eligibility Criteria
Inclusion
- female patients aged 20-70 years scheduled for modified radical mastectomy with axillary dissection for breast carcinoma
Exclusion
- known allergy to the study drugs significant organ dysfunction drug or alcohol abuse epilepsy patients with chronic pain or regularly receiving analgesics any psychiatric illness that would interfere with the perception and the assessment of pain
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06499090
Start Date
March 1 2024
End Date
December 1 2027
Last Update
January 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
south Egypt Cancer Institute Assiut University
Asyut, Egypt